Skip to main content
ABCL filings

Corporate insider profile

John S. Montalbano Filing Activity

Latest reported as Corporate insider of AbCellera Biologics Inc. (ABCL).

Purchase filings
2
Reported companies
1
Net open-market value
$205,700
Latest transaction
Aug 18, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 18, 2026AbCellera Biologics Inc. (ABCL)Corporate insiderOpen Market Purchase10,000$11.03$110,300
May 14, 2026AbCellera Biologics Inc. (ABCL)Corporate insiderOpen Market Purchase20,000$4.77$95,400